Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni GuangDong
    • By Beroni Tianjin
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
Menu Close
  1. Home>
  2. 2018>
  3. December>
  4. 29>
  5. 2018>
  6. New Year Address of Beroni Group
You are currently viewing New Year Address of Beroni Group

New Year Address of Beroni Group

  • Post author:admin
  • Post published:2018-12-29
  • Post category:2018

You Might Also Like

Read more about the article 2017-2018 Annual General Meeting of Beroni Group was held successfully

2017-2018 Annual General Meeting of Beroni Group was held successfully

2018-02-13
Read more about the article H. E. Yukio Hatoyama, Former Prime Minister of Japan attending The Second Precision Medicine & Medical Care and Aging International Forum

H. E. Yukio Hatoyama, Former Prime Minister of Japan attending The Second Precision Medicine & Medical Care and Aging International Forum

2018-12-21
Read more about the article Cooperation between Beroni and Columbia University on ArboViroPlex rRT-PCR Test Research Program

Cooperation between Beroni and Columbia University on ArboViroPlex rRT-PCR Test Research Program

2018-03-26

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (6)
  • 2024 (8)
  • 2025 (1)

What’s New

  • Beroni Pharmaceuticals Nucleic Acid Drug CRO Services
  • Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough
  • Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy
  • Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases
  • Beroni Group’s Ten-year Research Journey, Innovation Leads the Future

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu